RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Non-or minimally invasive monitoring methods using particle delivery methods

  • US 6,482,604 B2
  • Filed: 03/12/2001
  • Issued: 11/19/2002
  • Est. Priority Date: 09/04/1998
  • Status: Expired due to Fees
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save
    ×



    ×

    Thank you for your feedback

    ×
    ×